APOC3 and coronary artery disorder: Changes in APOC3 levels caused by APOC3-adjacent variants were associated with a reduced risk of CAD (OR 0.90, P = 0.009) (Figure 2A), as were changes in TG levels through APOC3-adjacent variants (OR 0.80, P = 4 × 10−11).